Skip to content

Fluid management during laparoscopic upper gastrointestinal surgery

Fluid management during laparoscopic upper gastrointestinal surgery - Fluid management during laparoscopic upper gastrointestinal surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022351
Enrollment
140
Registered
2016-06-01
Start date
2016-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients scheduled laparoscopic gastrointestinal surgery

Interventions

Patients are randomized to either restricted fluid therapy or liberal fluid therapy. Restricted fluid therapy group receive 1-2ml/kg/h of crystalloids. Hypotension (mean blood pressure &lt
60mmhg) is treated by administration of phenylephrine. If hypotension can not be treated, 200ml boluses of colloids (hydroxyethyl starch solutions) are given. Liberal fluind therapy group receive 7-1
60mmhg) is treated by administration of phenylephrine. Blood loss is replaced by colloids for both groups.

Sponsors

Osaka Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients scheduled laparoscopic upper gastrointestinal surgery ASA physical status classification (1-3)

Exclusion criteria

Exclusion criteria: Patients who require hemodialysis Patients who have a history of pacemaker implantation Patients who required converting to open surgery Patients whose intraoperative blood loss exceeded 500ml

Design outcomes

Primary

MeasureTime frame
30-day postoperative complications

Secondary

MeasureTime frame
Ratio of extracellular water to total body water measured by bioimpedance analysis Postoperative body weight Length of hospital stay Need for postoperative diuretic treatment Postoperative hypotension

Countries

Japan

Contacts

Public ContactYusuke Kusaka

Osaka Medical College Department of Anesthesiology

ane063@osaka-med.ac.jp+81-72-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026